Psoriasis associated with rofecoxib

Archives of Dermatology

Volumn 139, Issue 9, 2003, Pages 1223-

  Clark, David Walter John ^a   Coulter, David Morris ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ROFECOXIB;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HUMAN; NECK INJURY; PRIORITY JOURNAL; PSORIASIS; TREATMENT OUTCOME;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; FEMALE; HUMANS; LACTONES; MIDDLE AGED; PSORIASIS; SPRAINS AND STRAINS; SULFONES;

EID: 0141484628     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.139.9.1223     Document Type: Article

References (5)

1. Coulter DM. The New Zealand Intensive Medicines Monitoring Programme in Pro-active Safety Surveillance. Pharmacoepidemiol Drug Saf. 2000;9:273-280.
2. Meyerhoff JO. Exacerbation of psoriasis with meclofenamate. N Engl J Med. 1983;309:496.
3. Ben-Chetrit E, Rubinow A. Exacerbation of psoriasis by ibuprofen. Cutis. 1986;38:45.
4. Smith AG. Skin disorders. In: Davies DM, Ferner RE, de Glanville H, eds. Davies's Textbook of Adverse Drug Reactions. 5th ed. London, England: Chapman & Hall; 1998:566-584.
5. Higgs GA, Eakins KE, Mugridge KG, Moncada S, Vane JR. The effects of non-steroidal anti-inflammatory drugs on leukocyte migration in carrageenin induced inflammation. Eur J Pharmacol. 1980;66:81-86.